Baxter International (FRA:BTL) 3-Year Revenue Growth Rate : 9.00% (As of Dec. 2023)

View and export this data going back to . Start your Free Trial

What is Baxter International 3-Year Revenue Growth Rate?

Baxter International's Revenue per Share for the three months ended in Dec. 2023 was €7.04.

During the past 12 months, Baxter International's average Revenue per Share Growth Rate was 1.70% per year. During the past 3 years, the average Revenue per Share Growth Rate was 9.00% per year. During the past 5 years, the average Revenue per Share Growth Rate was 8.00% per year. During the past 10 years, the average Revenue per Share Growth Rate was 5.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of Baxter International was 29.30% per year. The lowest was -32.20% per year. And the median was 5.60% per year.

Competitive Comparison of Baxter International's 3-Year Revenue Growth Rate

For the Medical Instruments & Supplies subindustry, Baxter International's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Baxter International's 3-Year Revenue Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Baxter International's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Baxter International's 3-Year Revenue Growth Rate falls into.

Baxter International 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

Baxter International (FRA:BTL) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

Baxter International 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Baxter International's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Baxter International (FRA:BTL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Baxter International Inc (FRA:BTL) » Definitions » 3-Year Revenue Growth Rate

Comparable Companies

Traded in Other Exchanges

BAX:USA 1BAX:Italy BAX:Austria

Address

One Baxter Parkway, Deerfield, IL, USA, 60015

Website

https://www.baxter.com

Baxter offers a variety of medical instruments and supplies to caregivers. It enhanced its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment, including hospital beds, to the portfolio, although about half of Hillrom's revenue comes from more digitally connected offerings like its smart beds and Voalte medical communications app. From its legacy operations, Baxter offers tools to help patients with acute and chronic kidney failure, which it plans to spin off by mid-2024. It also sells a variety of injectable therapies for use in care settings, such as IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents.

Baxter International (FRA:BTL) Headlines

No Headlines